Article
Pharmacogenetic Testing in the Clinical Management of Schizophrenia
13 Sept 2005
Abstract excerpt
Clinical application of pharmacogenetic testing has been proposed as a means of improving treatment outcomes in psychiatry. The identification of a putative genetic test for better clozapine response in schizophrenia offers an opportunity to evaluate the cost-effectiveness of such testing. The authors performed a cost-effectiveness analysis of a genetic test that may identify individuals with greater likelihood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
